Rosenthal DS - Search Results

1

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.

Stone RM, Maguire M, Goldberg MA, Antin JH, Rosenthal DS, Mayer RJ. Stone RM, et al. Among authors: rosenthal ds. Blood. 1988 Mar;71(3):690-6. Blood. 1988. PMID: 3422828 Free article.

2

Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

Antin JH, Smith BR, Holmes W, Rosenthal DS. Antin JH, et al. Among authors: rosenthal ds. Blood. 1988 Aug;72(2):705-13. Blood. 1988. PMID: 3042046 Free article.

3

Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?

Goldberg MA, Ginsburg D, Mayer RJ, Stone RM, Maguire M, Rosenthal DS, Antin JH. Goldberg MA, et al. Among authors: rosenthal ds. Blood. 1987 Jan;69(1):187-91. Blood. 1987. PMID: 3466655 Free article.

4

Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update.

Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD. Weinstein HJ, et al. Among authors: rosenthal ds. Blood. 1983 Aug;62(2):315-9. Blood. 1983. PMID: 6575837 Free article.

5

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.

Wheeler C, Antin JH, Churchill WH, Come SE, Smith BR, Bubley GJ, Rosenthal DS, Rappaport JM, Ault KA, Schnipper LE, et al. Wheeler C, et al. Among authors: rosenthal ds. J Clin Oncol. 1990 Apr;8(4):648-56. doi: 10.1200/JCO.1990.8.4.648. J Clin Oncol. 1990. PMID: 2313334

6

Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes.

Griffin JD, Mayer RJ, Weinstein HJ, Rosenthal DS, Coral FS, Beveridge RP, Schlossman SF. Griffin JD, et al. Among authors: rosenthal ds. Blood. 1983 Sep;62(3):557-63. Blood. 1983. PMID: 6309279 Free article.

7

The treatment of acute myelogenous leukemia in children and adults: VAPA update.

Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD, Nathan DG, Frei E 3rd. Weinstein HJ, et al. Among authors: rosenthal ds. Haematol Blood Transfus. 1983;28:41-5. doi: 10.1007/978-3-642-68761-7_8. Haematol Blood Transfus. 1983. PMID: 6345291 Clinical Trial. No abstract available.

8

Treatment of acute myelogenous leukemia in children and adults.

Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E 3rd. Weinstein HJ, et al. Among authors: rosenthal ds. N Engl J Med. 1980 Aug 28;303(9):473-8. doi: 10.1056/NEJM198008283030901. N Engl J Med. 1980. PMID: 6930539

9

VAPA10: a treatment program for acute myelocytic leukemia.

Mayer RJ, Weinstein HJ, Rosenthal DS, Coral FS, Nathan DG, Frei E 3rd. Mayer RJ, et al. Among authors: rosenthal ds. Haematol Blood Transfus. 1981;26:45-52. doi: 10.1007/978-3-642-67984-1_6. Haematol Blood Transfus. 1981. PMID: 6947937 No abstract available.

10

Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.

Antin JH, Weinberg DS, Rosenthal DS. Antin JH, et al. Among authors: rosenthal ds. Exp Hematol. 1990 May;18(4):266-70. Exp Hematol. 1990. PMID: 2182331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters